Blar i Department of Clinical Medicine på forfatter "Af Geijerstam, Solveig Amdahl"
-
NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease
Berven, Haakon; Kverneng, Simon Ulvenes; Sheard, Erika; Søgnen, Mona; Af Geijerstam, Solveig Amdahl; Haugarvoll, Kristoffer; Skeie, Geir Olve; Dölle, Christian; Tzoulis, Charalampos (Journal article; Peer reviewed, 2023)Nicotinamide adenine dinucleotide (NAD) replenishment therapy using nicotinamide riboside (NR) shows promise for Parkinson’s disease (PD) and other neurodegenerative disorders. However, the optimal dose of NR remains ...